期刊文献+

支气管哮喘气道重塑的研究进展 被引量:51

原文传递
导出
摘要 支气管哮喘(哮喘)是一种以气道高反应性和可逆性气流受限为特征的慢性气道炎症性疾病。随着疾病的进展,以气道结构变化为特征的气道重塑逐渐加重,气道重塑的出现可导致不同程度的不可逆性气流受限,使哮喘患者对常规治疗药物反应性降低甚至抵抗[1]。本文就气道重塑的病理基础、发生机制、对哮喘的影响及相关的干预研究进展做一综述。
出处 《中华肺部疾病杂志(电子版)》 CAS 2015年第6期97-100,共4页 Chinese Journal of Lung Diseases(Electronic Edition)
  • 相关文献

参考文献43

  • 1李喆,莫琳芳,任成山.支气管哮喘药物治疗现状及进展[J].中华肺部疾病杂志(电子版),2014,7(5):78-80. 被引量:58
  • 2Tanabe T, Kanoh S, Tsushima K, et al. Clarithromycin Inhibits lnterleukin- 13-Induced Goblet Cell Hyperplasia in Human Airway Cells[J]. Am J Respir Cell Mol Biol, 2011,45(5) : 1075-1083.
  • 3Silva MA, Bercik P. Macrophages are related to goblet ceil hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells[J]. Lab Invest, 2012, 92(6) : 937-948.
  • 4Bergeron C, Tulic MK, Hamid Q. Airway remodelling in asthma: from benchside to clinical practice [ J ]. Can Respir J, 2010, 17(4) : e85-e93.
  • 5Halwani R, A1-Muhsen S, A1-Jahdali H, et al. Role of transforming growth factor-13 in airway remodeling in asthma [ J]. Am J Respir Cell Mol Biol, 2011, 44(2) : 127-133.
  • 6Yang YC, Zhang N, Van Crombruggen K, et al. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling [ J ]. Allergy, 2012, 67 (10) : 1193- 1202.
  • 7Firszt R, Francisco D, Church TD, et al. Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-131 in airway fihroblasts in asthma [ J ]. Eur Respir J, 2014, 43(2) : 464-473.
  • 8Kelly EA, Jarjour NN. Role of matrix metalloproteinases in asthma [J]. Curr Opin Pulm Med, 2003, 9(1) : 28-33.
  • 9Shifren A, Witt C, Christie C, et al. Mechanisms of Remodeling in Asthmatic Airways[ J]. J Allergy ( Cairo), 2012:316049.
  • 10Gerthoffer WT. Migration of airway smooth muscle cells [ J ]. Proc Am Thorac Soc, 2008, 5 ( 1 ) : 97-105.

二级参考文献68

  • 1包爱华,周新.氧化应激及抗氧化治疗与支气管哮喘[J].中华哮喘杂志(电子版),2012,6(5):359-365. 被引量:9
  • 2Bateman ED, Hurd SS, Bames PJ, et al. Global strategy for asthma management and preention: GINA executive summary [ J ]. Eur Respir J, 2008, 31 ( 1 ) : 143-178.
  • 3Douglas G, Higgins B, Barnes N, et al. British Guideline on the Management of Asthma [ J ]. Thorax, 2008, 63 ( Suppl 4 ) : ivl 1- ivl21.
  • 4陈小东,金美玲.支气管哮喘[M]//陈灏珠,林果为,王吉耀.实用内科学.第14版.北京:人民卫生出版社,2013:1701-1711.
  • 5Schrder NW, Corther TR, Naiki Y, et al. Innate immune responese during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization [ J ]. J Allergy Chn Immunol, 2008, 122 : 595-602.
  • 6Patel KK, Vicencio AG, Du Z, et al. Infectious chlamydia pneumoniae is associated with elevated interleukin-8 and airway neutrophilia in children with refractory asthma[J]. Pediatr Infect Dis J, 2010, 29: 1093-1098.
  • 7Loymans R J, Gemperli A, Cohen J, et al. Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis[ J]. BMJ, 2014, 348:g3009 doi: 10. 1136/ bmj. g3009.
  • 8Bateman ED, Izquierdo JL, Harnest U, et al. Efficacy and safety of lofluilast in the treatment of asthma [ J 1. Ann Allergy Asthma lmmunol, 2006, 96(5): 679-686.
  • 9Deng YM, Xie QM, Tang HF, et al. Effects of ciclamilast, a new PDE 4 PDEA inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma [ J 1. Eur J Pharmacol, 2006, 547(1/3) : 25-135.
  • 10Hamelmann E. The rationale for treating allergic asthma with antilgE [J]. Eur Respir Rev, 2007, 16(104) : 61-66.

共引文献104

同被引文献698

引证文献51

二级引证文献471

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部